Current Studies

CEBIO contributes to clinically and methodologically relevant studies in liquid biopsy, molecular diagnostics, and reference materials. Here you’ll find a selection of ongoing projects we are involved in – from clinical centers and inter-lab comparisons to method validation studies.

External Quality Assurance in Liquid Biopsy

Validating molecular methods under real-world conditions is essential for clinical reliability. CEBIO actively contributes to inter-lab comparison programs for liquid biopsy – in collaboration with our partners QuoData and new_diagnostics. The aim is to assess and improve laboratories’ analytical performance in cfDNA-based diagnostics using standardized, real-life conditions.

Using biologically relevant reference materials and statistically sound evaluation procedures, the program supports quality assurance and method harmonization in molecular diagnostics.

Visit the EQA program at QuoData

Project Summary: The international inter-lab comparison program “EQA for Molecular Pathology and Liquid Biopsies” is conducted in partnership with QuoData and new_diagnostics. It targets diagnostic laboratories using technologies such as digital PCR or NGS to analyze circulating tumor DNA (ctDNA). CEBIO provides standardized cfDNA samples and methodological expertise.